GB Patent

GB9212308D0 — Therapeutic compositions

Assigned to Imperial Chemical Industries Ltd · Expires 1992-07-22 · 34y expired

What this patent protects

Benz[b]azepine compounds, pharmaceutical compositions containing them and methods for the treatment of neurological disorders utilizing them.

USPTO Abstract

Benz[b]azepine compounds, pharmaceutical compositions containing them and methods for the treatment of neurological disorders utilizing them.

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: GB9212308D0
Jurisdiction: GB
Classification: —
Expires: 1992-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Imperial Chemical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.